Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ · Healthcare
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $2.18B
- P/E ratio
- —
- EPS
- —
- Volume
- 1,309,236
- 52-week high
- —
- 52-week low
- —
- Open
- $22.95
- Day high
- $23.27
- Day low
- $22.28
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $172.35M | -$285.42M | -$3.29 |
| 2024 | $23.68M | -$318.76M | -$3.72 |
| 2023 | $0 | -$209.36M | -$2.98 |
| 2022 | $0 | -$149.34M | -$2.46 |
| 2021 | $139.71M | $24.93M | $0.46 |
About Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm focused on developing innovative therapies for cancer. Among its leading investigational products are SNDX-5613, currently undergoing Phase 1/2 clinical assessment, which targets the Menin-mixed lineage leukemia 1 protein interaction for treating MLL-rearranged (MLLr) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1c AML). Another significant candidate is SNDX-6352, or axatilimab, a monoclonal antibody designed to block the colony stimulating factor 1 (CSF-1) receptor, intended for patients suffering from chronic graft versus host disease (cGVHD). The company is additionally progressing Entinostat. Syndax has also established strategic collaborations, including a research and development agreement with the National Cancer Institute, a clinical trial agreement with the Eastern Cooperative Oncology Group, and a license agreement with Kyowa Hakko Kirin Co., Ltd. Founded in 2005, Syndax Pharmaceuticals, Inc. maintains its corporate headquarters in Waltham, Massachusetts.
- CEO
- Michael A. Metzger
- Employees
- 270
- Country
- US
- IPO date
- Mar 2, 2016
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Syndax Pharmaceuticals, Inc.'s stock price today?
- SNDX is trading at $22.29 as of Jul 20, 2026.
- What is Syndax Pharmaceuticals, Inc.'s market cap?
- Syndax Pharmaceuticals, Inc. (SNDX) has a market capitalization of $2.18B.
- Does Syndax Pharmaceuticals, Inc. pay a dividend?
- Syndax Pharmaceuticals, Inc. did not pay a dividend in its most recent reported fiscal year.
- What sector is Syndax Pharmaceuticals, Inc. in?
- Syndax Pharmaceuticals, Inc. operates in the Healthcare sector.